River Street Advisors LLC Buys 7,491 Shares of Zoetis Inc. $ZTS

River Street Advisors LLC increased its position in shares of Zoetis Inc. (NYSE:ZTS) by 207.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,105 shares of the company’s stock after purchasing an additional 7,491 shares during the quarter. River Street Advisors LLC’s holdings in Zoetis were worth $1,625,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Nova Wealth Management Inc. bought a new stake in shares of Zoetis during the 1st quarter worth approximately $25,000. Halbert Hargrove Global Advisors LLC raised its position in Zoetis by 496.6% during the third quarter. Halbert Hargrove Global Advisors LLC now owns 173 shares of the company’s stock valued at $25,000 after purchasing an additional 144 shares in the last quarter. REAP Financial Group LLC raised its position in Zoetis by 201.5% during the second quarter. REAP Financial Group LLC now owns 196 shares of the company’s stock valued at $31,000 after purchasing an additional 131 shares in the last quarter. NewSquare Capital LLC lifted its stake in Zoetis by 69.1% during the second quarter. NewSquare Capital LLC now owns 208 shares of the company’s stock worth $32,000 after purchasing an additional 85 shares during the last quarter. Finally, 1248 Management LLC acquired a new stake in shares of Zoetis in the 1st quarter valued at $35,000. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

ZTS has been the subject of several recent analyst reports. Stifel Nicolaus dropped their price objective on Zoetis from $140.00 to $130.00 and set a “hold” rating for the company in a research report on Tuesday, November 18th. HSBC set a $140.00 target price on Zoetis in a research note on Wednesday, December 10th. JPMorgan Chase & Co. reduced their price target on shares of Zoetis from $230.00 to $200.00 and set an “overweight” rating on the stock in a research note on Wednesday, November 5th. Argus reaffirmed a “buy” rating and set a $190.00 price target on shares of Zoetis in a report on Tuesday, September 9th. Finally, Bank of America downgraded shares of Zoetis from a “buy” rating to a “neutral” rating and set a $135.00 price objective for the company. in a research note on Monday, December 15th. Six research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $160.18.

Zoetis Stock Performance

NYSE:ZTS opened at $125.77 on Monday. The stock’s 50-day moving average is $125.02 and its 200-day moving average is $141.51. Zoetis Inc. has a 1-year low of $115.25 and a 1-year high of $177.40. The company has a current ratio of 3.64, a quick ratio of 2.28 and a debt-to-equity ratio of 1.31. The stock has a market cap of $55.43 billion, a P/E ratio of 21.17, a price-to-earnings-growth ratio of 2.57 and a beta of 0.97.

Zoetis (NYSE:ZTS) last posted its earnings results on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, topping the consensus estimate of $1.62 by $0.08. Zoetis had a net margin of 28.21% and a return on equity of 57.19%. The business had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.42 billion. During the same period last year, the company earned $1.58 EPS. The firm’s revenue was up .5% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Equities research analysts anticipate that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 3rd. Investors of record on Tuesday, January 20th will be issued a $0.53 dividend. The ex-dividend date is Tuesday, January 20th. This is a positive change from Zoetis’s previous quarterly dividend of $0.50. This represents a $2.12 dividend on an annualized basis and a yield of 1.7%. Zoetis’s dividend payout ratio (DPR) is currently 33.67%.

Zoetis Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.